Wednesday 27 September 2017 12:25pm
Athletes and the body-conscious beware – at least six sports supplements on sale in Australia and New Zealand contain anabolic steroids not declared on their labels.
Designer anabolic steroids, also known as androgens, pose a potential health risk and, for athletes, may lead to a positive doping test and a ban from competing in a sport.
The study, published in the International Journal of Sport Nutrition and Exercise Metabolism, was carried out by researchers from the University of Otago and the University of Technology Sydney.
Research leader Professor Alison Heather, of the Department of Physiology in Otago’s School of Biomedical Sciences, says athletes use supplements hoping they will make them more competitive and healthy.
“Sports supplements, as well as other forms of nutritional supplements, are very popular with athletes, at the professional, amateur and recreational levels. In some sports, 100 per cent of the athletes use such supplements, such as in body-building.
“Some members of the general population also take them in the hope they might improve body image or vitality.”
The sports supplement market is not well regulated and manufacturers can market their products with unsubstantiated claims, she says.
“Unfortunately, sports supplements are usually marketed without rigorous scientific, clinical safety and efficacy data. There is no legal requirement for proof-of-benefit claims.
“Supplements can contain ingredients that may have useful properties. However, due to poor manufacturing practices or adulteration, sports supplements can contain compounds that are banned for use in sports, but that are not included on the label as an ingredient.”
European studies have shown up to 16 per cent of sports supplements contain a banned substance.
Professor Heather’s research focuses on developing cell bioassays that can detect any bioactive androgen that is able to switch on an androgen response. These bioassays provide a generic detection for any androgen, regardless of chemical structure.
Using such an assay, members of her laboratory team screened 116 sports supplements bought over-the-counter in Australia, many of which are also marketed in New Zealand. One of the products that tested positive is actually made in, and distributed from, New Zealand.
“We simply went into supplement retailers, or bought online, supplements that were being marketed for athletes as ‘performance-enhancing’ products. We specifically chose supplements that did not state on their labels that they contained an androgen.
“We found that 5.4 per cent of the supplements tested positive for an androgen. That means more than one in 20 contained anabolic steroids that the users would be unaware of if they were relying on information on their labels.
“The supplements we tested included protein powders, pre-workout formulations, fat metabolisers, vitamins and herbal extracts.
“Sports supplements contaminated or adulterated with androgens are a major concern because, for the unsuspecting consumer, they pose a potential health risk, while for an athlete it could result in a positive doping test,” Professor Heather says.
In 2015, a report showed 95 per cent of elite New Zealand athletes consumed sports supplements, which followed a report a year earlier that 70 per cent of New Zealand first XV rugby players regularly took supplements.
“Our research shows that there is a real risk for health and doping violations that athletes must consider when taking sports supplements, even those sold over the counter,” she says.
For more information, please contact:
Professor Alison Heather
Department of Physiology, School of Biomedical Sciences
University of Otago
Tel: +64 3 479 7399
A list of Otago experts available for media comment is available elsewhere on this website.
Electronic addresses (including email accounts, instant messaging services, or telephone accounts) published on this page are for the sole purpose of contact with the individuals concerned, in their capacity as officers, employees or students of the University of Otago, or their respective organisation. Publication of any such electronic address is not to be taken as consent to receive unsolicited commercial electronic messages by the address holder.